RAF265(CHIR-265)

Description Biological Activity

Product Name: RAF265(CHIR-265)
CAS No.: 927880-90-8
Chemical Name: RAF265(CHIR-265)
Synonyms: RAF265;CS-1852;RAF265, >=98%;RAF265(CHIR-265);CHIR-265 or RAF265;RAF265 or CHIR-265;CHIR265;RAF-265;CHIR 265;;RAF265(CHIR-265) USP/EP/BP;RAF265 (CHIR-265);RAF-265; CHIR265;1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]-oxy]-N-[4-(trifluoromethyl)
CBNumber: CB92526152
Molecular Formula: C24H16F6N6O
Formula Weight: 518.41
MOL File: 927880-90-8.mol

More

Less

RAF265(CHIR-265) Property

Boiling point:: 667.6±65.0 °C(Predicted)
Density: 1.50
storage temp.: Store at -20°C
solubility: ≥25.9 mg/mL in DMSO; insoluble in H2O; ≥7.97 mg/mL in EtOH with ultrasonic
pka: 9.07±0.27(Predicted)
form: Solid
color: White to khaki
Sensitive: Light Sensitive

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

N-Bromosuccinimide Price

Alfa Aesar

Product number: J67037
Product name: RAF265
Packaging: 5mg
Price: $305
Updated: 2023/06/20

Alfa Aesar

Product number: J67037
Product name: RAF265
Packaging: 10mg
Price: $567
Updated: 2023/06/20

Cayman Chemical

Product number: 16991
Product name: RAF265
Purity: ≥98%
Packaging: 1mg
Price: $44
Updated: 2024/03/01

Cayman Chemical

Product number: 16991
Product name: RAF265
Purity: ≥98%
Packaging: 5mg
Price: $172
Updated: 2024/03/01

Cayman Chemical

Product number: 16991
Product name: RAF265
Purity: ≥98%
Packaging: 10mg
Price: $257
Updated: 2024/03/01

More

Less

RAF265(CHIR-265) Chemical Properties,Usage,Production

Description

RAF265, also known as (CHIR-265), is an arylaminobenzimidazole-based B-RAF, C-RAF, and VEGFR2 inhibitor developed by Chiron Corporation, later acquired by Novartis.

Biological Activity

RAF265 is a novel, orally active, small molecule with potent inhibitory activity against B-Raf kinase and additional antiangiogenic activity through inhibition of vascular endothelial growth factor receptor type 2 (VEGFR-2) in non-clinical studies.

Uses

RAF265 (CHIR-265) is an oral, highly selective RAF and VEGFR kinase inhibitor with IC50 of of 5 to 10 μM.

Uses

RAF 265 is a multikinase inhibitor that has displayed BRAF inhibiting activity in clinical trials. It could be used in the treatment of a subpopulation of human melanoma tumors. Has cytotoxic effect of on MDA-MB-231 cells. RAF265 when used with BEZ-235 inhibited ERK, PI3K signaling that reduced growth, proliferation and development of drug resistance in human thyroid cancer cells.

Definition

ChEBI: 1-methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-2-benzimidazolamine is an aromatic ether.

Biological Activity

raf265, also known as chir-265, is a novel and orally available small molecule inhibitor of multiple intracellular kinases, including brafv600e, braf (wild-type), c-raf, vascular endothelial growth factor receptor 2 (vegfr2), platelet-derived growth factor receptor (pdgfr), colony-stimulating factor (csf) 1r, ret, c-kit, src and ste20, with half maximal inhibitory concentration ic50 ranging from less than 20 nmo/l to more than 100 nmol/l, in which it exhibits the highest potency for brafv600e and vegfr2 with half maximal effective concentration ec50 of 0.14 μm and 0.19 μm respectively. raf265 has been found to inhibit proliferation of melanoma and colorectal cancer cell lines with active braf mutations and time- and dose-dependently suppress tumor regression in brafv600e melanoma and colorectal cancer xenograft models.

target

B-Raf

References

[1]huang t1, karsy m, zhuge j, zhong m, liu d. b-raf and the inhibitors: from bench to bedside. j hematol oncol. 2013 apr 25;6:30. doi: 10.1186/1756-8722-6-30.
[2]garcia-gomez a1, ocio em, pandiella a, san miguel jf, garayoa m. raf265, a dual braf and vegfr2 inhibitor, prevents osteoclast formation and resorption. therapeutic implications. invest new drugs. 2013 feb;31(1):200-5. doi: 10.1007/s10637-012-9845-3. epub 2012 jul 7.
[3]su y1, vilgelm ae, kelley mc, hawkins oe, liu y, boyd kl, kantrow s, splittgerber rc, short sp, sobolik t, zaja-milatovic s, dahlman kb, amiri ki, jiang a, lu p, shyr y, stuart dd, levy s, sosman ja, richmond a. raf265 inhibits the growth of advanced human melanoma tumors. clin cancer res. 2012 apr 15;18(8):2184-98. doi: 10.1158/1078-0432.ccr-11-1122. epub 2012 feb 20.

RAF265(CHIR-265) Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

RAF265(CHIR-265) Suppliers

Canada 1 China 93 India 2 United Kingdom 1 United States 20 Global 117

AdooQ BioScience, LLC

Tel: +1 (866) 930-6790
Fax: +1 (866) 333-9607
Email: info@adooq.com
Country: United States
ProdList: 2782
Advantage: 58

Target molecule Corp.

Tel: 857-239-0968
Fax: 857-239-8801
Email: service1@targetmol.com
Country: United States
ProdList: 2559
Advantage: 60

Musechem

Tel: +1-800-259-7612
Fax: +1-800-259-7612
Email: info@musechem.com
Country: United States
ProdList: 4660
Advantage: 60

TargetMol Chemicals Inc.

Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Country: United States
ProdList: 32161
Advantage: 58

InvivoChem

Tel: +1-708-310-1919 +1-13798911105
Fax: 708-557-7486
Email: sales@invivochem.cn
Country: United States
ProdList: 6391
Advantage: 58

Cckinase, Inc.

Tel: +1 (732)236-3202
Email: sales@cckinase.com
Country: United States
ProdList: 2738
Advantage: 58

Alchem Pharmtech,Inc.

Tel: 8485655694
Email: sales@alchempharmtech.com
Country: United States
ProdList: 63687
Advantage: 58

Aladdin Scientific

Tel: +1-+1(833)-552-7181
Email: sales@aladdinsci.com
Country: United States
ProdList: 57505
Advantage: 58

TargetMol Chemicals Inc.

Tel
Email: support@targetmol.com
Country: United States
ProdList: 38631
Advantage: 58

ApexBio Technology

Tel: --
Fax: --
Email: sales@apexbt.com
Country: United States
ProdList: 6251
Advantage: 58

United States Biological

Tel: --
Fax: --
Email: sales@advtechind.com
Country: United States
ProdList: 6075
Advantage: 58

BOC Sciences

Tel: 16314854226
Email: info@bocsci.com
Country: United States
ProdList: 9923
Advantage: 65

Alfa Chemistry

Tel: --
Fax: --
Email: info@Alfa-Chemistry.com
Country: United States
ProdList: 6814
Advantage: 0

Cayman Chemical Company

Tel: --
Fax: --
Email: cayman@caymanchem.com
Country: United States
ProdList: 6213
Advantage: 81

United States Biological

Tel: --
Fax: --
Email: chemicals@usbio.net
Country: United States
ProdList: 6214
Advantage: 80

Creative Enzymes

Tel: --
Fax: --
Email: info@creative-enzymes.com
Country: United States
ProdList: 6057
Advantage: 58

Matrix Scientific

Tel: --
Fax: --
Email: sales@matrixscientific.com
Country: United States
ProdList: 6632
Advantage: 80

NE Scientific

Tel: --
Fax: --
Country: United States
ProdList: 5030
Advantage: 55

Selleck Chemicals LLC

Tel: --
Fax: --
Email: info@selleckchem.com
Country: United States
ProdList: 824
Advantage: 60

Santa Cruz Biotechnology, Inc.

Tel: --
Fax: --
Email: scbt@scbt.com
Country: United States
ProdList: 3597
Advantage: 60

More

Less

View Lastest Price from RAF265(CHIR-265) manufacturers

Career Henan Chemical Co

Product: RAF265(CHIR-265) 927880-90-8
Price: US $2.00/kg
Min. Order: 1kg
Purity: 99%
Supply Ability: 100kg
Release date: 2018-12-23

927880-90-8, RAF265(CHIR-265)Related Search:

Selumetinib Imatinib Trametinib Veliparib Olaparib Vandetanib

RAF265(CHIR-265)

RAF265

CHIR-265 or RAF265

1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amine

1-methyl-5-(2-(5-(trifluoromethyl)-1H-imidazol-2-yl)pyridin-4-yloxy)-N-(4-(trifluoromethyl)phenyl)-1H-benzo[d]imidazol-2-amine

1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amine RAF265 (CHIR-265)

RAF 265 1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amine

CS-1852

CHIR265;RAF-265;CHIR 265;

1H-Benzimidazol-2-amine, 1-methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-

RAF265, >=98%

1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine

RAF265 (CHIR-265);RAF-265; CHIR265

1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]-oxy]-N-[4-(trifluoromethyl)

RAF265 or CHIR-265

RAF265(CHIR-265) USP/EP/BP

927880-90-8

C24H16F6N6O

MAPK

Inhibitors